In my bracketed annotations about 2/3 of the way into the post it says: “PharmAthene also has a larger Protexia grant from the NIH.”
I should have said smaller, not larger. PharmAthene’s Protexia grant from the NIH ($1.7M) is very much smaller than its Protexia grant from the DoD ($213M, including $35M in the first phase). Apologies for the misstatement.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”